JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Chapters
Summary
Here, we describe a protocol in which an acute lymphoblastic leukemia patient-derived xenograft model is used as a strategy to assess and monitor CD19-targeted chimeric antigen receptor T cell-associated toxicities.